As the MCOs get slammed over higher outpatient utilization in Medicare, we spent a little time today on CI which, on a top line basis, is levered to dug inflation and, on a bottom line basis, having some success cross selling to pharmacy "members. The name has been been a long in Tom Tobin's microsquad screen and seems to be in a good spot to avoid the negatives in Medicare Advantage and Medicaid disenrollment.
Link to replay:
Health Policy/Health Policy Unplugged Subscribers CLICK HERE for event details (includes video and materials link)
https://app.hedgeye.com/feed_items/134566?with_category=48-health-policy
Timestamps:
|
0:00 - 5:05: Introduction and thesis points 5:05 - 9:19 Drug channel - PCE, price and quantity, CPI & PPI; evidence of inflation and volume acceleration 9:19 - 11:09 Inflation (non) drivers - PPI, labor, imports in drug channel 11:09 - 16:08 Inflation drivers - shortages, excess mortality especially cancer 16:08 - 18:16 Inflation because you can; complexity of drug channel, gross to net bubble 18:16 - 22:49 Inflation because you want to; retention of rebate and spread pricing to reduce premiums and underwrite SG&A 22:49 - 28:31 Inflation because the law allows; role of Inflation Reduction Act in the near term; spread pricing 28:31 - 36:07 Health Care segment; Insured Medical Consumer Model and employment rate 36:07 - 39:33 Guidance - mostly about the drug channel |
Emily Evans
Managing Director – Health Policy
Twitter
LinkedIn
